Literature DB >> 28057197

Contraindication of live vaccines in immunocompromised patients: an estimate of the number of affected people in the USA and the UK.

L Varghese1, D Curran2, E Bunge3, H Vroling3, F van Kessel3, A Guignard2, G Casabona2, A Olivieri2.   

Abstract

Entities:  

Year:  2016        PMID： 28057197     DOI： 10.1016/j.puhe.2016.10.013

Source DB:  PubMed          Journal:  Public Health        ISSN： 0033-3506            Impact factor:   2.427


× No keyword cloud information.
  5 in total

1.  Precision immunization: a new trend in human vaccination.

Authors:  Siyue Jia; Jingxin Li; Yuanbao Liu; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

2.  Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.

Authors:  Maite Ramírez; Saritza Santos; Osmarie Martínez; Ricardo Rodríguez; Eric Miranda; Willy D Ramos-Perez; Miguel Otero
Journal:  Vaccine       Date:  2018-03-07       Impact factor: 3.641

3.  Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012.

Authors:  Emad A Yanni; Germano Ferreira; Morgane Guennec; Yassine El Hahi; Amale El Ghachi; François Haguinet; Emmanuelle Espie; Veronique Bianco
Journal:  BMJ Open       Date:  2018-06-07       Impact factor: 2.692

4.  Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009-2014.

Authors:  Cintia Muñoz-Quiles; Mónica López-Lacort; Javier Díez-Domingo; Alejandro Orrico-Sánchez
Journal:  BMC Infect Dis       Date:  2020-11-30       Impact factor: 3.090

5.  Immunization by Replication-Competent Controlled Herpesvirus Vectors.

Authors:  David C Bloom; Robert K Tran; Joyce Feller; Richard Voellmy
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.